FIELD: chemistry.
SUBSTANCE: group of inventions relates to chemiluminescent substrates and includes compounds of formulas (I-3) and (I-4), acid addition salts thereof, combinations for measuring chemiluminescence, containing them, method for quantitative analysis of coagulation factor in sample and method for quantitative analysis of anticoagulant in sample. In formulas (I-3) and (I-4), r is 0, 1, 2 or 3; r' is 0, 1, 2 or 3; d is 0, 1 or 2; g is 0 or 1; g' is 1; X is a terminal residue selected from OH, O(C1-6-alkyl), (OCH2CH2)1-6OH, (OCH2CH2)1-6O(C1-6-alkyl), NHC(=O)(O)0-1(C1-6-alkyl), NHC(=O)(O)0-1(C1-6-alkylene)(OCH2CH2)1-6OH, NHC(=O)(O)0-1(C1-6-alkylene)(OCH2CH2)1-6O(C1-6-alkyl), NHC(=O)(O)0-1(C1-6-alkylene)O(C1-6-alkyl), NHC(=O)(O)0-1(C1-6-alkylene)OH.
EFFECT: compounds of formulas (I-3) and (I-4) as chemiluminescent substrates for measuring blood coagulation factors.
19 cl, 20 dwg, 14 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MEASURING REACTIVITY OF FVIII | 2015 |
|
RU2752595C2 |
ANTIBODY WHICH IS CAPABLE OF NEUTRALIZING A SUBSTANCE HAVING AN ACTIVITY OF AN ALTERNATIVE COAGULATION FACTOR FUNCTION VIII (FVIII) | 2015 |
|
RU2737145C2 |
METHOD FOR EVALUATING REACTION OF BLOOD COAGULATION | 2013 |
|
RU2683933C2 |
CONJUGATED FACTOR VIII MOLECULES | 2009 |
|
RU2573587C2 |
PROCOAGULANT ANTIBODIES | 2018 |
|
RU2810094C2 |
MODIFIED FACTOR VII-BASED POLYPEPTIDES AND THEREOF APPLICATION | 2008 |
|
RU2571931C2 |
PURIFICATION OF FACTOR VIII SUBTYPES | 2018 |
|
RU2800431C2 |
PHARMACEUTICAL PREPARATION THAT IS ABLE TO ACCELERATE BLOOD COAGULATION PROCESS, A METHOD OF BLOOD COAGULATION ACCELERATION IN VITRO, USE OF AN INHIBITOR OF EPI-ACTIVITY AS A SUBSTANCE ACCELERATING BLOOD COAGULATION PROCESS | 1991 |
|
RU2127600C1 |
CONJUGATED PROTEINS WITH PROLONGED ACTION IN VIVO | 2009 |
|
RU2526804C2 |
HOST CELL CONTAINING VECTOR FOR PRODUCING PROTEINS REQUIRING GAMMA-CARBOXYLATION | 2006 |
|
RU2415934C2 |
Authors
Dates
2024-05-31—Published
2019-10-17—Filed